tiprankstipranks
Newbury Pharmaceuticals AB (SE:NEWBRY)
:NEWBRY
Sweden Market
NEWBRY
Newbury Pharmaceuticals AB
RESEARCH TOOLSreports

Newbury Pharmaceuticals AB (NEWBRY) Financial Statements

0 Followers

Newbury Pharmaceuticals AB Financial Overview

Newbury Pharmaceuticals AB's market cap is currently kr66.57M. The company's EPS TTM is kr-0.59; its P/E ratio is -2.74; Newbury Pharmaceuticals AB is scheduled to report earnings on July 8, 2026, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Aug 24Aug 23Aug 22Aug 21
Income Statement
Total Revenuekr 36.83Mkr 10.27Mkr 5.52Mkr 2.83M
Gross Profitkr 16.03Mkr 3.95Mkr 1.56Mkr 460.00K
Operating Incomekr -14.08Mkr -19.59Mkr -14.67Mkr -5.62M
EBITDAkr -12.14Mkr -18.33Mkr -13.66Mkr -4.91M
Net Incomekr -15.40Mkr -19.43Mkr -14.67Mkr -5.56M
Balance Sheet
Cash & Short-Term Investmentskr 15.30Mkr 8.53Mkr 33.33Mkr 13.14M
Total Assetskr 90.87Mkr 72.92Mkr 86.91Mkr 42.81M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00
Net Debtkr -15.30Mkr -8.53Mkr -33.33Mkr -13.14M
Total Liabilitieskr 38.95Mkr 23.54Mkr 18.14Mkr 4.34M
Stockholders' Equitykr 51.92Mkr 49.38Mkr 68.77Mkr 38.47M
Cash Flow
Free Cash Flowkr -26.62Mkr -24.09Mkr -39.40Mkr -27.15M
Operating Cash Flowkr -23.71Mkr -23.23Mkr -15.00Mkr -4.07M
Investing Cash Flowkr -2.95Mkr -862.00Kkr -24.40Mkr -26.73M
Financing Cash Flowkr 33.44Mkr -717.00Kkr 59.59Mkr 43.95M
Currency in SEK

Newbury Pharmaceuticals AB Earnings and Revenue History

Income Statement >

Newbury Pharmaceuticals AB Debt to Assets

Balance Sheet >

Newbury Pharmaceuticals AB Cash Flow

Cash Flow >

Newbury Pharmaceuticals AB Forecast EPS vs Actual EPS

Earnings >